RONNIE L. WHITE, District Judge.
This diversity case is before the Court on the motions of Express Scripts, Inc. (Defendant) (1) for summary judgment on Counts I and II of the First Amended Complaint (FAC) of HHCS Pharmacy, Inc., doing business as Freedom Pharmacy (Plaintiff); (2) to exclude the expert testimony of Jed Grennan on the question of Plaintiffs damages; and (3) for summary judgment on Counts III, V, and VII of the FAC. [ECF Nos. 78, 95, 97] Plaintiff opposes each motion.
Defendant is a pharmacy benefits manager. (FAC ¶8, ECF No. 47.) In this role, Defendant contracts with insurance carriers, health plan administrators, and other third-party payors "to facilitate delivery of prescription drugs to health plan members or other beneficiaries." (Blaies Decl. ¶6, ECF No. 25.) This facilitation is effectuated, in part, by the creation of networks established with various pharmacies that agree to fill prescriptions for the members. (Id. ¶7.) Plaintiff was one such pharmacy. (FAC Ex. 1, ECF No. 47 Ex. 1.)
In May 2014, Defendant entered into a Pharmacy Provider Agreement (the "Agreement") with Plaintiff. (Id.) This Agreement defined "Pharmacy" as one which met its definition of "Retail Provider": "[A] pharmacy that primarily fills and sells prescriptions via a retail, storefront location . . ." (Id. at 1, 2.) A `"Retail Provider' [did] not include mail order . . ." (Id. at 2.) Also,
(Id. at 4.) If the Provider "cease[d] to be licensed by the appropriate licensing authority" or if Defendant "determine[d] that the Provider was dispensing Covered Medications in violation of any applicable law, rule and/or regulation," the Agreement could be immediately terminated by Defendant. (Id. at 6.) Defendant's Provider Manual (the "Manual") is incorporated into the Agreement and also requires the Provider to "maintain valid non-resident licenses in all states to which it mails/ships/delivers Covered Medications." (Def.'s Stat. of Unconverted Material Facts ("SUMF") ¶¶ 4, 7; ECF No. 101.) If a Provider violates any terms of the Agreement, including the Manual, the Provider is deemed noncompliant and is subject to further action, including termination, at Defendant's sole discretion. (Manual at 34; ECF No. 25, Ex. 3.)
The Agreement authorized Defendant to audit a Provider and allowed for the Provider to appeal any results. (FAC Ex. 1 at 4-15.) This audit could include reviewing documentation verifying that the Provider has pharmacy and pharmacist licenses, "including licenses/permits/registrations required by states m which legend prescriptions are shipped/mailed." (Manual at 34.) The initial audit report and a deadline for appeal of such are given the Provider. (Lown Dep. at 11, ECF No. 100-9 at 4.) After review by the post-audit team, a final report and deadline for grieving the report is given the Provider. (Id. at 11-12.) Any discrepancies identified are reviewed and any appropriate adjustments are then made. (Id. at 12.)
In November 2015, Jorge Miranda, an auditor for Defendant, conducted an audit of Plaintiff. (Miranda Dep. at 28, 36, ECF No. 110-2.) "During an audit, [Defendant] typically reviews a subset of prescription claims that the pharmacy submitted to [Defendant]." (Blaies Decl. ¶ 19, ECF No. 25.) Of the claims selected for the audit of Plaintiff, Miranda checked beforehand to determine whether Plaintiff had the appropriate active non-resident state licenses. (Miranda Dep. at 48.) It did not. (Id.) Specifically, Plaintiff did not have non-resident licenses for Minnesota, North Carolina, New Jersey, Ohio, South Dakota, and Texas, but "mailed, shipped, and/or delivered one or more prescriptions" to these six states. (SUMF ¶¶ 10-21.) Each of these states require by regulation or statute that pharmacies shipping or mailing prescriptions into that state have a permit or license to do so. (See Def.'s Mem. at 7, n.5; ECF No. 79 (listing relevant provision for the six states)).
By letter dated December 3, 2015, Defendant forwarded to Plaintiff the results of the audit. (Blaies Decl. Ex. 4; ECF No. 27-5.) The dates of the eighty-one prescriptions cited in the Discrepancy Evaluation Report ranged from October 27, 2014 to October 9, 2015. (Id. at 4-13.) The discrepancy at issue for seventy-seven was "Unauthorized Mail [UM]"; for three was "Overbilled Q[uantity] [OB]"; and for one was both UM and OB. (Id.) Plaintiff appealed these findings. (Blaies Decl. ¶ 24.) One finding relating to an OB discrepancy reduced the amount at issue from $68.86 to $54.14, but the findings were unchanged that Plaintiff had mailed seventy-eight prescriptions to states for which it did not have a non-resident license. (Blaies Decl. Exs. 27-5 at 4-13, 27-6 at 4-13.) Subsequently, Plaintiff was notified that the chargeback amount was reduced to $126,441.04. (Blaise Decl. Ex. 27-6 at 2.) Plaintiff was also notified that the "[t]inalization of th[e] audit [did] not preclude further action on behalf of [Defendant's] clients." (Id.)
Defendant took further action, informing Plaintiff by letter of June 13, 2016 that Defendant was terminating its Agreement with Plaintiff and, effective July 18, 2016, would no longer consider Plaintiff to be a member of Defendant's provider network. (Blaise Decl. Ex. 10 at 3.) This letter cited two reasons for the termination. (Id.) First, Plaintiff had failed to maintain its required status as a "Retail Provider" and was instead primarily conducting a mailorder business. (Id.) Second, Plaintiff was "regularly mailing drugs to members in states without the appropriate licensure." (Id.)
Plaintiff does not dispute that it was mailing drugs to states for which it had no active non-resident license or that those states require such. Rather, Plaintiff argues it was in the process of applying for the needed licenses and it should have been, but was not, given an opportunity to correct the lack of licenses. Plaintiff further argues that the real reason for its termination from the network was Defendant's desire to gain market share by diverting highprice pharmaceuticals to a mail-order enterprise, Accredo Health Group, Inc. ("Accredo"),
Plaintiff seeks redress for Defendant's alleged (1) breach of the Agreement by terminating Plaintiff from the network of participating pharmacies (Count I); (2) breach of the implied duty of good faith and fair dealing (Count II); (3) unjust enrichment (Count III); and (4) breach of contract by failing to pay Plaintiff monies owed (Count VII). Plaintiff also seeks a declaratory judgment defining the parties' rights and responsibilities under the Agreement (Count V).
Defendant seeks summary judgment on these five remaining counts.
The Court may grant a motion for summary judgment "if the pleadings, depositions, answers to interrogatories, and admissions on file, together with the affidavits, if any, show that there is no genuine issue as to any material fact and that the moving party is entitled to judgment as a matter of law." Celotex Corp. v. Catrett, 477 U.S. 317, 322 (1986) (citing Fed.R.Civ.P. 56(c), the predecessor to Rule 56(a)). "The movant `bears the initial responsibility of informing the . . . [C]ourt of the basis for its motion,' and must identify `those portions of [the record] . . . which it believes demonstrate the absence of a genuine issue of material fact."' Torgerson v. City of Rochester, 643 F.3d 1031, 1042 (8
"`Under Missouri law,
The Agreement, including the incorporated Provider Manual, required Plaintiff to maintain non-resident licenses in states to which it shipped prescriptions. Plaintiff did not do so. "`[I]f a party, by contract, is obligated to a performance that is possible to be performed, the party must make good unless performance is rendered impossible by an Act of God, the law, or the other party."' Rohr v. Reliance Bank, 826 F.3d 1046, 1053 (8
Plaintiff argues, however, that the parties' course of dealing and performance modified their Agreement. As noted by Plaintiff, Mo.Rev.Stat. § 400.2-202(a)
Plaintiff also argues that Defendant breached their Agreement because the behavior for which it was allegedly terminated existed before the Agreement and continued after the Agreement was executed. This argument is unavailing. The Agreement was entered into in May 2014; Plaintiff was audited in November 2015. The dates of the unauthorized mailings ranged from October 2014 to October 2015. Moreover, where as in the instant case, the terms of the contract are clear and unambiguous, proffered "extrinsic evidence of the parties' intentions and past dealings is barred under Missouri law by the parol evidence rule." Union Elec. Co. v. Consolidation Coal Co., 188 F.3d 998, 1002 (8
The President and Chief Executive Officer of Plaintiff, N. Lois Adams, testified that she believed she was in good standing based on a history of having done business with "Express Scripts and its predecessors" since 1963. (Adams Dep. at 34-35, ECF No. 101-1 at 5.) Evidence of a course of dealing or performance is admitted only "to explain or supplement the terms of an agreement . . ., but not to contradict the agreement terms." JR. Waymire Co. v. Antares Corp., 975 S.W.2d 243, 247 (Mo.Ct.App. 1998) (excluding evidence of oral modification of written agreement to exclude entity as potential buyer of property in action seeking payment of commission after sale was made to that entity).
Allowing Adams' testimony about the parties' pnor dealings would contradict the Agreement, not explain or supplement it. First, Adams did not differentiate between Defendant and its predecessors. Second, her argument ignores the inclusion in the Agreement of a clause providing that "[n]o waiver of a breach of any covenant or condition shall be construed to be a waiver of any subsequent breach. No act, delay, or omission done, suffered, or permitted by the parties shall be deemed to exhaust or impair any right, remedy, or power of the parties hereunder." (Agreement at 11.) Cf Smith Flooring, 713 F.3d at 935-36, 940-41 (allowing testimony about parties' prior insurance contracts when later ones did not exclude certain buildings from coverage as had prior contracts and testimony established that parties meant to, and thought they had, excluded buildings as previously). Third, her argument also ignores the provision reading "[t]his Agreement, including its . . . Provider Manual, . . . constitutes the entire agreement of the parties with respect to the subject matter herein and, upon execution by the parties, supersedes all prior oral or written agreements between the parties with respect to the subject matter hereof." (Agreement at 10.) In Missouri, "[t]he inclusion of a merger or integration clause in the written contract makes `[t]he parol evidence rule . . . particularly applicable."' Smiley v. Gary Crossley Ford, Inc., 859 F.3d 545, 553 (8
Plaintiffs position that the Agreement was supplemented or explained by the parties' prior dealings is further defeated by the failure of Adams, the signor of the Agreement, to read it. Asked if she knew the Agreement required Plaintiff to be licensed in states to which it shipped prescriptions, Adams replied, "Now I do." (Adams Dep. at 35, ECF No. 101-1 at 5.) When signing the Agreement, she did not realize she was agreeing to follow all state board of pharmacies' rules and regulations. (Id. at 35-36.) She had not reviewed or read the Agreement before signing it, and had never talked about the Agreement to the administrative assistant who had read it. (Id. at 35-37.) `"Missouri law presumes that a party had knowledge of the contract he or she signed, and those who sign a contract have a duty to read it and may not avoid the consequences of the agreement on the basis that they did not know what they were signing.'" Bertocci v. Thoroughbred Ford, Inc., ___ S.W.3d ___ 2017 WL 4242018, *5 (Mo.Ct.App. 2017) (quoting Grossman v. Thoroughbred Ford, Inc., 297 S.W.3d 918, 922 (Mo.Ct.App. 2009)).
Plaintiff contends that the presence of the waiver and integration clauses and Adams' failure to read the Agreement is irrelevant because Defendant's true motivation was to divert the mail-order pharmacy business to its wholly-owned subsidiary. (See Pl. Resp. at 2, 10.) Plaintiff offers no evidence to support this position. "Conclusory affidavits do not provide a basis upon which to deny motions for summary judgment." Armour and Co. v. Inver Grove Hts., 2 F.3d 276, 279 (8
A primary consideration when construing the terms of a contract is whether its plain language "clearly addresses the matter at issue." TAP Pharm. Prods., Inc. v. State Bd. of Pharmacy, 238 S.W.3d 140, 143 (Mo. 2007) (en bane). If so, "the inquiry ends." Id. For the reasons set forth above, the Court's inquiry in Count I is at an end. Count I will be dismissed.
"Under Missouri law . . ., a covenant of good faith and fair dealing is implied in every contract, but `there can be no breach of the implied . . . covenant . . . where the contract expressly permits the actions being challenged, and the defendant acts in accordance with the express terms of the contract."' CitiMortgage v. Chicago Bancorp, Inc., 808 F.3d 747, 751 (8
Plaintiffs first allegation in support of its Count II claim lacks factual support. Rather, the undisputed evidence is that Plaintiff did not have the required non-resident licenses. Although Plaintiff takes issue with Defendant "target[ing]" those prescriptions shipped to states where Plaintiff did not have the appropriate licenses, there is no evidence to support that this was selective enforcement of the Agreement's provision authorizing Defendant to conduct an audit to verify that a Provider, e.g., Plaintiff, was complying with the Agreement and the Provider Manual.
Plaintiffs second allegation — that Defendant breached its implied duty by acting in self-interest — is also without merit. The only support for this claim is Adams' description of Defendant's motivation. See Affordable Communities of Mo. V Federal Nat'l Mortg. Ass'n, 714 F.3d 1069, 1077 (8
"Under Missouri law, a plaintiff is entitled to restitution for unjust enrichment when (1) the defendant was enriched by the receipt of a benefit; (2) the enrichment was at the expense of the plaintiff; and (3) it would be unjust to allow the defendant to retain the benefit." PlaNet, 119 F.3d at 733. "The third element . . . is considered the most significant and the most difficult of the elements." Adams v. One Park Place Investors, LLC, 315 S.W.3d 742, 749 (Mo.Ct.App. 2010) (interim quotations omitted). Mere receipt of benefits does not establish the third element. Miller v. Horn, 254 S.W.3d 920, 924 (Mo.Ct.App. 2008).
Plaintiff argues that summary judgment on its unjust enrichment is defeated by the "material fact" that "Accredo, the wholly-owned subsidiary pharmacy of Defendant, has been established and taken market share from Plaintiff; this retention of the market share and resulting profits is unjust; and damages, in direct contradiction of Defendant's assertions, have been provided and established." (Pl. Resp. at 4.) Plaintiffs argument is unavailing. First, Plaintiff has failed to submit any admissible evidence in support. See_Crews v. Monarch Fire Prat. Dist., 829 F.3d 661, 667 (8
Plaintiff argues this Count is not ripe for summary judgment for the same reasons it advanced in support of Count I. As discussed above, Plaintiff has failed to show there is a genuine issue of material fact as to whether Defendant improperly terminated the Agreement after determining that Plaintiff was shipping prescriptions to states in which it not have the required licenses in violation of the Agreement.
Count VII will also be dismissed.
The admissible evidence before the Court establishes that Defendant had a right under its Agreement with Plaintiff to terminate that Agreement for Plaintiffs lack of required non-resident licenses for states to which it shipped medications and to recoup monies paid for those medications. Accordingly,
An appropriate Order of Dismissal shall accompany this Memorandum and Order.